Login
$AVAH
$11.72 +$0.08 (0.73%) Live

Company Executives

Officer Age In this role Joined 2025 pay Source
Jeff Shaner Also a director
President and Chief Executive Officer
53 Not stated 2017 $4,864,165
Matthew Buckhalter
Chief Financial Officer
37 Since 2024
2 years
2017 $1,930,314
Ed Reisz
Chief Administrative Officer
67 Not stated 2017 $1,971,025
Jerry Perchik
Chief Legal Officer and Secretary
68 Not stated 2024 Not reported
Deborah Stewart
Chief Accounting Officer
42 Not stated 2021 Not reported
Patrick Cunningham
Chief Compliance Officer
70 Not stated 2017 Not reported
Edwin C. Reisz
Chief Administrative Officer
Title from the Form 4 dated Aug 20, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 17, 2026 · updated by the 8-Ks of Aug 7, 2026 and Oct 2, 2026

Directors
6
serving now
Independent
5 of 6
stated in the proxy
Average tenure
5.0 years
from year joined
CEO also chairs the board
No
Rodney D. Windley
Director On board Independent Committees 2025 pay Source
Rodney D. Windley
2017
9 years
Independent None stated $252,000
Sam Weil
2025
1 year
Independent
Compensation Committee
Not stated
Victor F. Ganzi
Not stated Independent None stated $225,000
Brent Layton
Not stated Independent
Audit Committee
$212,500
Devin O’Reilly
Not stated Independent None stated Not stated
Jeff Shaner
Not stated Not independent
Clinical Quality Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Apr 17, 2026
Steven E. Rodgers
Designated by J.H. Whitney Capital Partners under the A&R Stockholders Agreement
Amount not stated

Director designated by J.H. Whitney Capital Partners under the A&R Stockholders Agreement.

With J.H. Whitney Capital Partners Open in proxy
Devin O’Reilly and Sam Weil
Designated by Bain Capital under the A&R Stockholders Agreement
Amount not stated

Directors designated by Bain Capital under the A&R Stockholders Agreement.

With Bain Capital Open in proxy
Certain selling stockholders affiliated with J.H. Whitney Capital Partners
Affiliated with J.H. Whitney Capital Partners
Amount not stated
2025

Selling stockholders affiliated with J.H. Whitney Capital Partners sold 10,000,000 shares of common stock in an underwritten offering, and later sold an additional 1,500,000 shares after full exercise of an over-allotment option.

With The Company (underwritten offering of common stock) Open in proxy
Affiliates of Bain Capital
Affiliates of Bain Capital, one of our Sponsors, held a controlling interest prior to October 2019 and currently hold a minority position
Approximately $0.4 million
fiscal year ended January 3, 2026

Subsidiaries paid Waystar under software agreements for payment processing, patient claim management and denial and appeal management.

With ZirMed, Inc. d/b/a Waystar Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support